2018
DOI: 10.1016/j.nano.2018.05.021
|View full text |Cite
|
Sign up to set email alerts
|

Lipid based nanocarriers: a translational perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
77
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 153 publications
(78 citation statements)
references
References 172 publications
0
77
0
1
Order By: Relevance
“…Nanocarriers can be widely classified as organic-based, inorganic-based, or a combination of both (Table 1) [5]. Organic nanocarriers are comprised of polymeric nanoparticles and lipid-based nanoparticles such as liposomes, nanoemulsions (e.g., micelles and reversed micelles), dendrimers, and carbon-based nanocarriers (e.g., fullerenes and carbon nanotubes).…”
Section: Classification Of Nanocarriersmentioning
confidence: 99%
“…Nanocarriers can be widely classified as organic-based, inorganic-based, or a combination of both (Table 1) [5]. Organic nanocarriers are comprised of polymeric nanoparticles and lipid-based nanoparticles such as liposomes, nanoemulsions (e.g., micelles and reversed micelles), dendrimers, and carbon-based nanocarriers (e.g., fullerenes and carbon nanotubes).…”
Section: Classification Of Nanocarriersmentioning
confidence: 99%
“…Drug delivery strategies are those aimed to improve the bioavailability of drugs by modulating their solubility, stability, circulation, targeting and biodistribution, subcellular transport, and/or release rate [169,170,171,172,173,174]. Therefore, these approaches help enhance the therapeutic value of drugs and minimize their toxicity [169,170,171,172,173,174].…”
Section: Alterations In the Vesicular Transport Of Cellsmentioning
confidence: 99%
“…Drug delivery strategies are those aimed to improve the bioavailability of drugs by modulating their solubility, stability, circulation, targeting and biodistribution, subcellular transport, and/or release rate [169,170,171,172,173,174]. Therefore, these approaches help enhance the therapeutic value of drugs and minimize their toxicity [169,170,171,172,173,174]. A variety of formulations have been designed for this purpose, from conjugates to nanoparticle carriers, including linear, branched and dendrimeric polymers, micelles, liposomes and polymersomes, several types of porous and solid particles, and modified versions of natural vesicles [172,173,174,175,176,177,178].…”
Section: Alterations In the Vesicular Transport Of Cellsmentioning
confidence: 99%
See 1 more Smart Citation
“…In later years, Professor Norio Taniguichi, a MIT-based American engineer, drew significant attention from a wider audience to the nanotechnological field. During the 1990s, many nanotechnological applications were derived from a specialized form of materials science [8]. However, these materials are currently used for a number of applications in various fields such as energy, electronics, food and agriculture, cosmetics, and healthcare.…”
Section: Introductionmentioning
confidence: 99%